65IB drugs, pharmaceuticals and hematology related products

Ended Awarded Last action

Contract number
V797D30092
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order 100% complete
IDV ceiling
$930,510,000.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment
Legislative mandates
  • Other statutory authority

Award details come from SAM.gov/FPDS.

IDV awards

IDV Agency Ceiling Awarded
VA797P17A0003 BPA for spinraza National Acquisition Center (VA) —

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00091 · Contract cancellation $0
Supplemental Agreement for work within scope P00090 · Small business subcontracting plan $0
Supplemental Agreement for work within scope P00089 · Product deletion $0
Supplemental Agreement for work within scope P00085 $0
Supplemental Agreement for work within scope P00087 $0
Supplemental Agreement for work within scope P00086 $0
Supplemental Agreement for work within scope P00088 · TPR $0
Supplemental Agreement for work within scope P00083 · Temporary contract extension $0
Supplemental Agreement for work within scope P00081 · Administrative change $0
Supplemental Agreement for work within scope P00078 $0
Supplemental Agreement for work within scope P00077 $0
Supplemental Agreement for work within scope P00082 $0
Supplemental Agreement for work within scope P00079 · TPR $0
Supplemental Agreement for work within scope P00080 · 2018 PL updates $0
Supplemental Agreement for work within scope P00076 · Admin POC change & signatory authority update $0
Other Administrative Action P00074 · POC change $0
Other Administrative Action P00073 · Modification issued to correct the name for NDC # 64406-0977-01 to factor IX, recombinant 4000 UNT/VIL INJ and the trade name to alprolix factor IX 40001U/VIL? $0
Other Administrative Action P00072 · TPR eloctate -OGA $0
Supplemental Agreement for work within scope P00071 · Product addition -temporary FCP -eloctate $0
Supplemental Agreement for work within scope P00069 · Permanent FCP price for alprolix $0
Other Administrative Action P00068 · Signatory form update $0
Supplemental Agreement for work within scope P00065 · Product addition -spinraza $0
Supplemental Agreement for work within scope P00061 · Temporary FCP aprolix -addition $0
Other Administrative Action P00064 · Signatory update $0
Supplemental Agreement for work within scope P00058 · Addition of spinraza $0
Other Administrative Action P00059 · Add specialty form for curascript. $0
Supplemental Agreement for work within scope P00057 $0
Supplemental Agreement for work within scope P00055 · 2017 PL $0
Vendor DUNS or Name Change - Non-Novation P00052 · Name change $0
Other Administrative Action P00051 · TPR $0
Supplemental Agreement for work within scope P00050 · Addition-alprolix $0
Other Administrative Action P00049 · SBA plan $0
Supplemental Agreement for work within scope P00048 $0
Supplemental Agreement for work within scope P00047 $0
Supplemental Agreement for work within scope P00046 $0
Supplemental Agreement for work within scope P00045 $0
Supplemental Agreement for work within scope P00044 · 65IB drugs, pharmaceuticals and hematology related products perm FCP stage $0
Supplemental Agreement for work within scope P00043 $0
Other Administrative Action P00042 · 65IB drugs, pharmaceuticals and hematology related products NDC change $0
Other Administrative Action P00041 · 65IB drugs, pharmaceuticals and hematology related products updated signatory authority $0
Other Administrative Action P00040 · 65IB drugs, pharmaceuticals and hematology related products NDC change $0
Other Administrative Action P00039 $0
Other Administrative Action P00038 · 65IB drugs, pharmaceuticals and hematology related products - incorporation of 2014 subcontracting plan $0
Supplemental Agreement for work within scope P00035 · 65IB drugs, pharmaceuticals and hematology related products temporary price reduction $0
Supplemental Agreement for work within scope P00034 · 65IB drugs, pharmaceuticals and hematology related products permanent price decrease $0
Other Administrative Action P00037 · Temporary price reductions $0
Supplemental Agreement for work within scope P00036 · Establishment of permanent FCP stage $0
Other Administrative Action P00033 · 65IB drugs, pharmaceuticals and hematology related products permanent price increase $0
Other Administrative Action P00031 $0
Other Administrative Action P00032 · 65IB drugs, pharmaceuticals and hematology related products TPR - $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Quick answers

Who was awarded contract V797D30092?

V797D30092 was awarded to Biogen U.s. Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on February 15, 2013.

How much is contract V797D30092 worth?

V797D30092's own ceiling is $930,510,000.

Who can order from contract V797D30092?

V797D30092 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract V797D30092 part of a contract vehicle?

Yes. V797D30092 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract V797D30092 competed?

The extent of competition for V797D30092 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV